FOMAT

ChAd3 vaccine

Two Anti-Ebola Vaccines in Historic Race

One of the most rapidly fast-tracked vaccines in history—an anti-Ebola “ChAd3” vaccine—just entered clinical trial in humans. It may wrap in November. It protected macaques for five weeks, leaping to 10 months when followed by a booster two months later. It…

Read More
Biosimilar drugs

FDA: Little Evidence to Support Testosterone Drugs

The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious testosterone therapy risks. The agency posted its…

Read More
25_08_2014

Genetics to Test Ebola Vaccine

An Iowa drug developer is preparing to test a possible Ebola vaccine in humans, as scientists race to develop ways to prevent or fight a virus that has killed more than 1,000 people in a West African outbreak. NewLink Genetics is…

Read More
Ebola outbreak

Debate Continues Over Experimental Ebola Drugs

In this photo taken on Tuesday, Aug. 12, 2014, Guinea soldiers stand around a rope across the road that separates Guinea and Sierra Leone, and works as a makeshift border control checkpoint at Gbalamuya-Pamelap, Guinea. As Guinea closed its border with…

Read More
Ethics of experimental treatment

Answers about an Unproven Drug for Ebola

Marie-Paule Kieny, Assistant Director General of the World Health Organization,WHO, informs the media following a panel of medical analysts to explore the ethics of experimental treatment in the Ebola outbreak, at the headquarters of the WHO in Geneva, Switzerland, Tuesday, Aug….

Read More